Oklo - Class A opened lower at $25.15, compared with its previous close of $26.81. In the last trading session, the stock traded between $24.51 and $25.48. It showed a downward intraday trend.
return calculator
Time Period
An investment of $100 made 3 years ago in Oklo - Class A is now worth
$ 300.09
giving a profit of
$ 200.09 (200.09%)
invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 14 Analysts
Buy
57.14%
Hold
42.86%
Sell
0%
Markets Today
Today's Change
$-1.45 (-5.42%)
Day High
$25.48
Day Low
$24.51
Day Open
$25.15
Prev Close
$26.81
Volume
35,01,872
1W Return
-6.00%
1M Return
-31.66%
3M Return
-31.17%
6M Return
-60.98%
1Y Return
-82.32%
Fundamentals
Market Cap ($ Mn)
4,717
PE Ratio
-
PB Ratio
2.27
PEG Ratio
-
ROE
-13.55%
ROCE
-17.27%
EPS (TTM)
-
Investment Returns
1 Week
-6.00%
1 Month
-31.66%
3 Months
-31.17%
6 Months
-60.98%
9 Months
-70.53%
Financials
Quarterly
All values in $ Mn
0.0
Dec 24
0.0
Mar 25
0.0
Jun 25
0.0
Sep 25
0.0
Dec 25
1.2
Jun 26
Updates
22Oct
Citigroup maintains Neutral on Oklo, cuts price target to $33
Citigroup maintains Neutral rating on Oklo Inc. Price target lowered from $57.5 to $33. Analyst Vikram Bagri oversees the rating action.
8 days ago
19Oct
Piper Sandler maintains Overweight on Oklo, cuts price target to $49
Piper Sandler maintains Overweight rating on Oklo Inc. Price target lowered from $55 to $49 by analyst Dimple Gosai. Rating action reflects a $6 reduction in target value.
11 days ago
13Oct
Oklo advances Groves isotope facility under US DOE launch pad initiative
Oklo Inc. selected for US DOE's Nuclear Energy Launch Pad initiative. Groves 2 Forge will produce lutetium-177 for targeted cancer treatments. Project builds on Groves Isotope Test Reactor deployment in Texas. Transition to commercial scale requires US NRC licensing.
17 days ago
21Sep
Oklo and NuScale stocks fall as SMR sector risks rise and dilution continues
Oklo and NuScale stocks fell 49% and 43% YTD respectively, handing short sellers over $2 billion in gains. NuScale diluted shareholders by increasing outstanding shares from 23 million in 2021 to 410 million after raising $750 million. Oklo raised $1 billion via share sale, increasing outstanding shares from 122 million in 2024 to 185 million. Both firms face a shortage of high-assay low-enriched uranium, with supply expected only in H2 2028.
1mo ago
18Sep
Oklo shares rise as House passes bill shielding residents from AI power costs
Oklo shares rose 0.63% to $39.90 in premarket trading. U.S. House passed Ratepayer Protection Act to shift AI power costs. Stock trades 36.3% below its 200-day simple moving average. Analyst consensus is Buy with an average price target of $85.46. Global X Uranium ETF holds a 5.37% weighting in Oklo.
1mo ago
11Sep
Oklo enters $1B ATM equity distribution agreement with 10 banks
Oklo may sell up to $1 billion of Class A common stock via ATM offering. Ten banks including Goldman Sachs and J.P. Morgan act as sales agents. Commission capped at 1.5% of gross sales proceeds per share sold. Sales can occur on NYSE, OTC markets, or through private negotiations.
